Printer Friendly

Coenzyme Q10 for Heart Failure: the Controversy.

As a component of the electron transport chain, CoQ10 plays a key role in energy production, and is therefore essential for all energy-dependent process, including myocardial contraction. Myocardial concentrations of CoQ10 are significantly lower in patients with congestive heart failure (CHF) than in healthy people, but these levels can be increased by oral administration of CoQ10. Numerous clinical trials have shown that CoQ10 supplementation improves symptoms, increases left ventricular ejection fraction, and decreases the number of hospitalizations in patients with CHF. In other studies, however, CoQ10 was of no benefit.

The conflicting results in the different studies might be explained in part by differences in patient populations. One of the negative studies was conducted at an inner-city hospital and a Veterans Affairs hospital. The participants in that study may have had a relatively high prevalence of alcoholism (alcoholic heart disease) and dietary inadequacies. Those factors, combined with the use of diuretics, could have led to clinically significant deficiencies of magnesium, thiamine, or other nutrients that are needed for normal cardiac function. The effectiveness of CoQ10 may be diminished when deficiencies of other cardioprotective nutrients are present.

Based on the available evidence, the nutritional treatment of CHF should include not only CoQ10, but all nutrients known to play a role in heart function.

Baggio E et al. Italian multicenter study on the safety and efficacy of coenzyme Q10 as adjunctive therapy in heart failure. Mol Aspects Med. 1994;15(Suppl):S287-S294.

Langsjoen PH et al. Long-term efficacy and safety of coenzyme Q10 therapy for idiopathic dilated cardiomyopathy. Am J Cardiol. 1990;65:521-523.

Morisco C et al. Effect of coenzyme Q10 in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investing. 1993;71:S134-S136.

by Alan R. Gaby, MD

drgaby@earthlink.net
COPYRIGHT 2009 The Townsend Letter Group
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Townsend Letter
Article Type:Report
Geographic Code:1USA
Date:Jun 1, 2009
Words:294
Previous Article:Coenzyme Q10 Improves Results of Coronary Bypass Surgery.
Next Article:Nattokinase for Hypertension.
Topics:


Related Articles
CoQ10 aids chronic heart failure patients.
Coenzyme Q10 improves endothelial function.
Conventional CoQ10 fails severe heart disease patients.
CoQ10/statin combination improves atherosclerosis treatment.
Coenzyme Q10 and cancer: enhancing treatment outcomes and improving chemotherapy tolerability.
Alleviating congestive heart failure with coenzyme Q10.
CoQ10 may prevent migraine in kids and teens.
Low plasma CoQ10 predicts mortality in heart failure patients.
Alternative strategies for reducing blood pressure.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |